Orthofix Medical Inc. Provision for Loan, Lease, and Other Losses
Orthofix Medical Inc. (OFIX) reported Provision for Loan, Lease, and Other Losses of $3.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2026-08-05
- Orthofix Medical Inc. provision for loan, lease, and other losses for the quarter ending 2026-06-30 was $2.87M, a 268.68% increase year-over-year.
- Orthofix Medical Inc. provision for loan, lease, and other losses for the quarter ending 2026-03-31 was $719.00K, a 32.04% decline year-over-year.
- Orthofix Medical Inc. provision for loan, lease, and other losses for the quarter ending 2025-12-31 was -$211.00K.
- Orthofix Medical Inc. provision for loan, lease, and other losses for the quarter ending 2025-09-30 was $629.00K, a 29.42% increase year-over-year.
- Orthofix Medical Inc. provision for loan, lease, and other losses for fiscal 2025 was $2.25M, a 12.81% increase from fiscal 2024.
- Orthofix Medical Inc. provision for loan, lease, and other losses for fiscal 2024 was $2.00M, a 143.78% increase from fiscal 2023.
- Orthofix Medical Inc. provision for loan, lease, and other losses for fiscal 2023 was $820.00K, a 60.86% decline from fiscal 2022.
- Orthofix Medical Inc. provision for loan, lease, and other losses for fiscal 2022 was $2.10M.
| Period end | Provision for Loan, Lease, and Other Losses 3 month | Provision for Loan, Lease, and Other Losses 6 month | Provision for Loan, Lease, and Other Losses 9 month | Provision for Loan, Lease, and Other Losses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.59M 10-Q · filed 2026-08-05 | $3.38M derived: sum of 3 quarters · filed 2026-08-05 | $4.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $719.00K 10-Q · filed 2026-05-05 | $508.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.14M derived: sum of 3 quarters · filed 2026-05-05 | $1.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $418.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.20M derived: sum of 3 quarters · filed 2026-08-05 | $2.25M 10-K · filed 2026-02-24 |
| 2025-09-30 | $629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.41M derived: sum of 2 quarters · filed 2026-08-05 | $2.47M 10-Q · filed 2025-11-04 | $2.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.84M 10-Q · filed 2026-08-05 | $1.78M derived: sum of 3 quarters · filed 2026-08-05 | $2.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.06M 10-Q · filed 2026-05-05 | $998.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.48M derived: sum of 3 quarters · filed 2026-05-05 | $1.68M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $426.00K derived: sum of 2 quarters · filed 2026-02-24 | $623.00K derived: sum of 3 quarters · filed 2026-02-24 | $2.00M 10-K · filed 2026-02-24 |
| 2024-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $683.00K derived: sum of 2 quarters · filed 2025-11-04 | $2.06M 10-Q · filed 2025-11-04 | $1.97M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.57M 10-Q · filed 2025-08-05 | $1.49M derived: sum of 3 quarters · filed 2026-02-24 | $1.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.38M 10-Q · filed 2025-05-06 | $1.29M derived: sum of 2 quarters · filed 2026-02-24 | $1.71M derived: sum of 3 quarters · filed 2026-02-24 | |
| 2023-12-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $330.00K derived: sum of 2 quarters · filed 2026-02-24 | $820.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $905.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $490.00K 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $2.10M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |